In silico high-resolution whole lung model to predict the locally delivered dose of inhaled drugs

Maximilian J. Grill,Jonas Biehler,Karl-Robert Wichmann,David Rudlstorfer,Maximilian Rixner,Marie Brei,Jakob Richter,Joshua Bügel,Nina Pischke,Wolfgang A. Wall,Kei W. Müller

2023-07-11

Abstract:The big crux with drug delivery to human lungs is that the delivered dose at the local site of action is unpredictable and very difficult to measure, even a posteriori. It is highly subject-specific as it depends on lung morphology, disease, breathing, and aerosol characteristics. Given these challenges, computational approaches have shown potential, but have so far failed due to fundamental methodical limitations. We present and validate a novel in silico model that enables the subject-specific prediction of local aerosol deposition throughout the entire lung. Its unprecedented spatiotemporal resolution allows to track each aerosol particle anytime during the breathing cycle, anywhere in the complete system of conducting airways and the alveolar region. Predictions are shown to be in excellent agreement with in vivo SPECT/CT data for a healthy human cohort. We further showcase the model's capabilities to represent strong heterogeneities in diseased lungs by studying an IPF patient. Finally, high computational efficiency and automated model generation and calibration ensure readiness to be applied at scale. We envision our method not only to improve inhalation therapies by informing and accelerating all stages of (pre-)clinical drug and device development, but also as a more-than-equivalent alternative to nuclear imaging of the lungs.

Medical Physics,Computational Engineering, Finance, and Science

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the difficulty in predicting and measuring the dose of local drug administration in the human lungs. Specifically, the actual effective dose of drugs at specific sites of action in the lungs is affected by multiple factors, including lung morphology, disease state, breathing patterns, and aerosol characteristics. These problems make it very difficult to verify the performance of drug - delivery devices and evaluate the bioequivalence of generic drugs. In addition, existing experimental methods, such as in - vitro tests, ex - vivo and in - vivo animal experiments, and in - vivo human studies, cannot provide sufficient information to accurately predict the local deposition of drugs in the lungs. In particular, although nuclear imaging techniques can provide certain spatial and temporal resolutions, their application scope is limited due to patient exposure to radiation and high costs.

To overcome the above challenges, this paper proposes a brand - new computer simulation method, aiming to predict the deposition of each aerosol particle in the entire lungs with high spatiotemporal resolution. This method can not only simulate the lungs of healthy people, but also show strong heterogeneity in diseased lungs (such as the lungs of patients with idiopathic pulmonary fibrosis). Through comparison and verification with in - vivo SPECT/CT data, the predictive ability of this model has been proven. Moreover, this model has high computational efficiency, and the model generation and calibration processes are automated, making large - scale applications possible. The authors of the paper hope that this method can not only improve inhalation therapy and accelerate all stages of drug and device development, but also serve as a powerful alternative to nuclear imaging techniques.